Myocardial Infarction and Non-contraceptive Estrogen Use
NCT00005185 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-05-13
Summary
To evaluate whether the use of noncontraceptive estrogen influenced the incidence of first myocardial infarction in women.
Conditions
- Cardiovascular Diseases
- Heart Diseases
- Myocardial Infarction
- Menopause
- Postmenopause
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Eligibility
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1986-04-30
- Completion
- 1990-03-31
More Related Trials
-
Estrogen, Cytokines and Heart Failure in Women
NCT00041431 ·Status: COMPLETED ·Phase: NA
-
Hormone Therapy Effects on CVD Risk Factors
NCT00006313 ·Status: COMPLETED
-
Estrogen Replacement and Atherosclerosis (ERA) in Older Women
NCT00000549 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
NCT00005108 ·Status: COMPLETED ·Phase: PHASE2
-
Midlife Cholesterol Study
NCT00361075 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Treatment Induced Premature Menopause on Quality of Life
NCT00185718 ·Status: COMPLETED
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death
NCT00580775 ·Status: COMPLETED
-
Hostility and Pathogenic Mechanisms of Coronary Heart Disease in Women
NCT00005435 ·Status: COMPLETED
-
Sex Steroid Hormones and Risk of CHD in Women
NCT00006407 ·Status: COMPLETED
-
Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women
NCT03815929 ·Status: COMPLETED ·Phase: PHASE2
-
Menopause Effects on Vascular Function
NCT03236545 ·Status: COMPLETED ·Phase: NA
-
CVD Risk and Health in Postmenopausal Phytoestrogen Users
NCT00000613 ·Status: COMPLETED ·Phase: PHASE2
-
A Longitudinal Study to Identify Mechanisms of Menopause on Cardiovascular Disease Risk
NCT05647876 ·Status: RECRUITING
-
Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
NCT00123539 ·Status: TERMINATED ·Phase: NA
-
Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
NCT04050592 ·Status: UNKNOWN ·Phase: PHASE4
-
Perimenopausal Estrogen Replacement Therapy Study
NCT01308814 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Estrogen Deficiency on Cardiovascular Risk
NCT06369363 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
NCT00000559 ·Status: COMPLETED ·Phase: PHASE3
-
Bioidentical 'Natural' Hormone Evaluation in Early Menopause
NCT00302731 ·Status: TERMINATED ·Phase: PHASE2
-
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
NCT03018366 ·Status: COMPLETED ·Phase: PHASE2
-
Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity
NCT05985447 ·Status: RECRUITING
-
Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters
NCT04453332 ·Status: UNKNOWN ·Phase: NA
-
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
NCT00001752 ·Status: COMPLETED ·Phase: PHASE2
-
Estrogen Use in Protection From Cognitive Decline
NCT00097058 ·Status: COMPLETED